Bayer HealthCare / Press

Bayer’s Eye Drug Recommended for EU Approval in Fifth Indication

The European Committee for Medicinal Products for Human Use (CHMP) has recommended aflibercept solution for injection into the eye for the treatment of visual impairment due to myopic choroidal neovascularization (myopic CNV) for approval in the EU. Myopic CNV is a disease of the retina associated with high degrees of myopia (near-sightedness) and frequently affects people of working age. more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.

  • TV Footage

    In this section you can find videos for editorial coverage. » more


    The video section provides an overview of interesting videos for viewing. » more

Bayer HealthCare Links

RSS Feed
RSS Feed

Copyright © Bayer HealthCare AG